89.80
-0.40
(-0.44%)
At close: January 10 at 4:00:21 PM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
625,280.00
262,902.00
302,125.00
195,174.00
Total Liabilities Net Minority Interest
145,620.00
154,695.00
150,662.00
115,165.00
Total Equity Gross Minority Interest
479,660.00
108,207.00
151,463.00
80,009.00
Total Capitalization
479,660.00
108,207.00
193,758.00
124,466.00
Common Stock Equity
479,660.00
108,207.00
151,463.00
80,009.00
Capital Lease Obligations
71,435.00
69,403.00
7,985.00
11,954.00
Net Tangible Assets
467,972.00
100,877.00
147,757.00
78,745.00
Working Capital
457,946.00
98,281.00
102,653.00
54,406.00
Invested Capital
479,660.00
108,207.00
195,919.00
126,609.00
Tangible Book Value
467,972.00
100,877.00
147,757.00
78,745.00
Total Debt
71,435.00
69,403.00
52,441.00
58,554.00
Share Issued
16,349.70
16,349.70
16,349.70
16,349.70
Ordinary Shares Number
16,290.43
16,349.70
16,349.70
16,349.70
Treasury Shares Number
59.27
--
--
--
12/31/2020 - 4/5/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
609.SG ABIONYX Pharma SA
1.2200
+0.33%
NAMSW NewAmsterdam Pharma Company N.V.
14.78
+3.50%
VLA.VI Valneva SE
2.2240
+4.81%
5CV.DE CureVac N.V.
4.2660
+9.61%
IFRX InflaRx N.V.
2.2300
-4.29%
SNGX Soligenix, Inc.
3.2000
-2.14%
ELAB PMGC Holdings Inc.
2.0600
-2.37%
ZEAL.CO Zealand Pharma A/S
735.00
+0.07%
CVM CEL-SCI Corporation
0.4252
+16.05%
NLSP NLS Pharmaceutics AG
2.3200
-3.73%